S&P 500 Consumer Staples Sector SEC Filings — February 25, 2026

26-02-2026

Kimbell Royalty Partners, LP filed an 8-K on February 26, 2026 (AccNo: 0001104659-26-020066, Size: 500 KB), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for financial results releases. No specific revenue, earnings, comparisons, positive or negative metrics, guidance, or other quantitative details are explicitly stated.

26-02-2026

Shenandoah Telecommunications Co/VA/ filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or period-over-period comparisons were disclosed in the filing summary. This is a standard earnings-related disclosure with all quantitative financial metrics NOT_DISCLOSED.

26-02-2026

Primo Brands Corp filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or strategic details are mentioned.

26-02-2026

Qnity Electronics, Inc. filed a Form 8-K on February 26, 2026, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard mandatory earnings-related disclosure with attached exhibits.

• ·Filing Accession Number: 0002058873-26-000007
• ·Filing Size: 681 KB
• ·Sector: NOT_DISCLOSED

26-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. Critical event content is missing, limiting assessment of impact.

26-02-2026

Celsius Holdings, Inc. filed a Form 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item informational filing typical for earnings releases.

26-02-2026

Clear Channel Outdoor Holdings, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard disclosure for financial results with attached statements. No specific revenue, earnings, guidance, period-over-period changes, or other metrics are disclosed in the provided filing information.

26-02-2026

Ellington Financial Inc. filed a Form 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, comparisons, or guidance in the available information. No positive, negative, or flat performance indicators are detailed.

26-02-2026

Hormel Foods Corp /DE/ filed an 8-K on February 26, 2026 (AccNo: 0000048465-26-000018), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. Sector is not specified.

• ·Filing size: 541 KB
• ·Event Type: Financial Results
• ·Source: us_sec

26-02-2026

Krispy Kreme, Inc. filed an 8-K on 2026-02-26 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

26-02-2026

J M Smucker Co filed an 8-K on February 26, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a multi-item filing with no specific revenue, earnings, guidance, or other quantitative financial metrics disclosed in the provided information. No positive or negative performance details, period-over-period comparisons, or strategic updates are mentioned.

26-02-2026

GigaCloud Technology Inc filed a Form 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a standard disclosure for financial results, likely related to quarterly or annual earnings. No specific revenue, earnings, guidance, or period-over-period metrics are detailed in the provided filing summary.

26-02-2026

Teleflex Inc filed a Form 8-K on February 26, 2026, reporting results of operations and financial condition (Item 2.02), costs associated with exit or disposal activities (Item 2.05), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This multi-item filing indicates quarterly financial results alongside restructuring or disposal-related costs, suggesting potential mixed performance with operational updates but added expenses. Specific revenue, earnings, cost amounts, guidance, or period-over-period changes are NOT_DISCLOSED.

26-02-2026

Aclaris Therapeutics, Inc. filed an 8-K on February 26, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results typically tied to an earnings release.

26-02-2026

Intellia Therapeutics, Inc. filed an 8-K on February 26, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information. This is a standard disclosure for financial results with no detailed quantitative data available.

26-02-2026

Delcath Systems, Inc. filed a Form 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition as part of its financial results announcement. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were mentioned in the provided filing information. All quantitative metrics and further details are NOT_DISCLOSED.

26-02-2026

Vericel Corp filed an 8-K on February 26, 2026 (AccNo: 0001628280-26-012003, Size: 378 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard mandatory disclosure for financial results without detailed outcomes available.

• ·AccNo: 0001628280-26-012003
• ·File Size: 378 KB
• ·Sector: not specified
• ·Event Type: Financial Results

26-02-2026

Bank of New York Mellon Corp filed an 8-K on February 26, 2026, reporting solely under Item 8.01 Other Events. No details on the specific event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive or negative metrics are mentioned.

26-02-2026

Koppers Holdings Inc. filed an 8-K on February 26, 2026 (AccNo: 0001315257-26-000010), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

26-02-2026

Nuwellis, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned in the provided filing information.

26-02-2026

STANDARD MOTOR PRODUCTS, INC. filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed quantitative data available.

26-02-2026

FRANKLIN ELECTRIC CO INC filed an 8-K on February 26, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. All quantitative and qualitative impacts are NOT_DISCLOSED.

26-02-2026

Clipper Realty Inc. filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or quantitative data were mentioned in the filing description. This is a standard financial results announcement without detailed performance indicators.

26-02-2026

Helios Technologies, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative metrics are provided in the filing summary. This appears to be a routine disclosure without additional context on governance or market implications.

26-02-2026

Elevance Health, Inc. filed an 8-K on 2026-02-26 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other numerical data mentioned.

26-02-2026

Insight Molecular Diagnostics Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001493152-26-008169), disclosing entry into a material definitive agreement under Item 1.01 and providing financial statements and exhibits under Item 9.01. No details on the agreement's parties, terms, value, strategic importance, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

• ·Filing size: 202 KB
• ·Accession Number: 0001493152-26-008169
• ·Sector: NOT_DISCLOSED

26-02-2026

Applied Optoelectronics, Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no detailed performance data available.

26-02-2026

Teledyne Technologies Inc filed an 8-K on 2026-02-26 under Items 1.01 and 9.01, disclosing entry into a material definitive agreement with financial statements and exhibits attached. No details on the agreement's nature, parties, value, strategic rationale, or financial impacts are provided in the filing summary. No quantitative metrics, period-over-period changes, or scheduled events are mentioned.

26-02-2026

NetApp, Inc. filed an 8-K on 2026-02-26 under Item 2.02 disclosing Results of Operations and Financial Condition and under Item 9.01 including Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or quantitative details are mentioned in the filing information provided. This is an informational earnings-related disclosure with no directional performance data available.

26-02-2026

Energy Fuels Inc filed a Form 8-K on February 26, 2026 (AccNo: 0001062993-26-001182, size 13 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of potentially material information via attached exhibits, but no specific events, transactions, metrics, positives, negatives, or flat performance are detailed. No quantitative financial data or comparisons provided.

26-02-2026

Helio Corp filed a Form 8-K on February 26, 2026, reporting changes in its certifying accountant under Item 4.01, a Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This multi-item filing highlights a potentially material event with the auditor change, which could signal concerns, while the Reg FD disclosure may contain additional information but lacks specifics here. No quantitative metrics, dollar values, or detailed reasons are disclosed.

26-02-2026

Elastic N.V. filed an 8-K on 2026-02-26 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a standard earnings-related disclosure. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are detailed in the provided filing information.

26-02-2026

TPG Inc. filed a Form 8-K on February 26, 2026, reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing triggered by significant corporate developments, but no specific transaction details, dollar values, financial metrics, or quantitative impacts are disclosed. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

26-02-2026

Relay Therapeutics, Inc. filed a Form 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics were mentioned in the filing description. This is a standard voluntary earnings-related disclosure with no directional performance indicators provided.

26-02-2026

Diamond Hill Investment Group Inc filed an 8-K on 2026-02-26 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard earnings-related disclosure with attached financial statements. No specific revenue, earnings, or other quantitative metrics are disclosed in the provided filing details.

26-02-2026

Dell Technologies Inc. filed an 8-K on February 26, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

26-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed.

26-02-2026

PureCycle Technologies, Inc. filed a multi-item Form 8-K on February 26, 2026, reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), material modifications to rights of security holders (Item 3.03), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This appears to be a comprehensive disclosure covering operational, governance, and strategic updates.

26-02-2026

OPKO Health, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-076575), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard voluntary earnings-related disclosure.

26-02-2026

DiamondRock Hospitality Co filed an 8-K on 2026-02-26 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure without quantified performance metrics.

26-02-2026

Clover Health Investments, Corp. /DE filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are detailed in the provided filing information. This represents a standard mandatory disclosure for financial results without quantified impacts.

26-02-2026

STIFEL FINANCIAL CORP filed an 8-K on February 26, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events are disclosed in the filing metadata provided.

26-02-2026

Alta Equipment Group Inc. filed an 8-K on February 26, 2026 (AccNo: 0001193125-26-076903), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. Sector details are not specified.

26-02-2026

Revelation Biosciences, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-076833), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were disclosed in the provided filing information. The filing size is 443 KB, with sector not specified.

26-02-2026

Monster Beverage Corp filed an 8-K on February 26, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. This is a standard earnings-related multi-item filing with no details on positive or negative performance.

26-02-2026

Ambarella Inc filed an 8-K on 2026-02-26 disclosing Results of Operations and Financial Condition under Item 2.02 and an officer change or election/appointment under Item 5.02, with exhibits under Item 9.01. Specific details on the affected officer position, whether it is an appointment or departure, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.

26-02-2026

Isabella Bank Corp filed a Form 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantitative data or performance metrics mentioned.

26-02-2026

Molina Healthcare, Inc. filed an 8-K on February 26, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. This appears to be a voluntary disclosure with no directional impact evident.

26-02-2026

Nelnet Inc filed an 8-K on February 26, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without quantified performance data.

• ·AccNo: 0001258602-26-000013
• ·File size: 5 MB
• ·Sector: not specified

26-02-2026

Morgan Stanley Direct Lending Fund filed an 8-K on February 26, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, or other financial metrics are disclosed in the provided filing description. This multi-item filing appears to be a voluntary disclosure of financial results.

26-02-2026

Markel Group Inc. filed an 8-K on 2026-02-26 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), with exhibits under Item 9.01. Specific details on affected positions, individuals involved, reasons for changes, timing, or impacts are NOT_DISCLOSED. No financial metrics, quantitative data, or scheduled events are mentioned.

26-02-2026

Proficient Auto Logistics, Inc. filed an 8-K on 2026-02-26 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are disclosed. No positive or negative metrics are provided, resulting in purely informational disclosure.

26-02-2026

Strawberry Fields REIT, Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001493152-26-008187, size 223 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. This is a multi-item informational filing with no quantitative metrics, positive or negative developments mentioned.

26-02-2026

Chemours Co filed an 8-K on February 26, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the filing summary provided. No quantitative data, period-over-period comparisons, or directional changes are mentioned.

26-02-2026

Columbus Circle Capital Corp II filed an 8-K on February 26, 2026, disclosing Other Events under Item 8.01 and attaching Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are provided in the filing summary. This is a multi-item, likely voluntary disclosure as Item 8.01 covers events not specified elsewhere.

26-02-2026

Eagle Bancorp Montana, Inc. filed an 8-K on 2026-02-26 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are disclosed. Filing size is 154 KB with AccNo 0001437749-26-005899.

• ·AccNo: 0001437749-26-005899
• ·Sector: NOT_DISCLOSED

26-02-2026

Technology & Telecommunication Acquisition Corp filed an 8-K on 2026-02-26 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. The filing also covers amendments to articles of incorporation or bylaws and potential change in fiscal year under Item 5.03, as well as submission of matters to a vote of security holders under Item 5.07, with financial statements and exhibits under Item 9.01. No specific transaction parties, terms, valuations, synergies, or financial metrics are disclosed.

26-02-2026

WHITE MOUNTAINS INSURANCE GROUP LTD filed an 8-K on February 26, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any financial statements or exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational filing with no quantified metrics or directional impacts mentioned.

• ·Filing Accession Number: 0001628280-26-012417
• ·Filing Size: 162 KB
• ·Multi-item 8-K: Items 8.01 and 9.01

26-02-2026

Palvella Therapeutics, Inc. filed an 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed.

• ·Filing Accession Number: 0001104659-26-020667
• ·File Size: 584 KB
• ·Event Date: 2026-02-26
• ·Sector: not specified
• ·Multi-item 8-K filing (Items 1.01 and 9.01)
• ·Mandatory disclosure under Item 1.01 for material agreements